Clinical Trials Browser

Phase 3 × Clear-cell metastatic renal cell carcinoma × 90 days × Clear all

NCT07011719 2026-03-13

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

Phase 3 Recruiting

Clear-cell metastatic renal cell carcinoma, Kidney Neoplasms